Chimerix, Inc.
Chimerix, Inc.'s email is info@chimerix-inc.com
and
Chimerix, Inc.'s phone number is 9193136782
.
Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. The company's lead candidate, CMX001, is being developed as a potential broad spectrum antiviral agent for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. Over 350 people have received CMX001 to date, with a growing body of evidence supporting the drug's antiviral activity in humans. Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/c...
read more
Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. The company's lead candidate, CMX001, is being developed as a potential broad spectrum antiviral agent for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. Over 350 people have received CMX001 to date, with a growing body of evidence supporting the drug's antiviral activity in humans. Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of cytomegalovirus (CMV) in hematopoietic stem cell transplant patients (CMX001-201), a Phase 2 study being initiated for the treatment of adenovirus (AdV) infection in pediatric and adult hematopoietic stem cell transplant patients (CMX001-202), and an Open-Label Study (CMX001-350) for the treatment of any of 12 different dsDNA viral infections, including AdV, herpes viruses such as CMV, herpes simplex virus and Epstein Barr virus, polyoma viruses such as BK virus and JC virus, and pox viruses. The Open-Label Study builds on Chimerix’s extensive experience working with clinicians at over 55 leading institutions in the United States, Canada, Europe and Israel who have sought CMX001 for the treatment of more than 150 immunocompromised patients under Emergency INDs. CMX001 has been well tolerated in all studies. CMX001 is also being developed as a medical countermeasure in the event of a smallpox release. Chimerix has received significant federal funding for the development of CMX001 as a medical countermeasure against smallpox from the National Institute of Allergy and Infectious Diseases. Chimerix's second clinical-stage antiviral compound, CMX157, a potent nucleoside analogue with in vitro activity against HIV and hepatitis B, has the potential to directly address several limitations of current HIV therapies. Chimerix is developing CMX157 for the treatment of HIV infection including those caused by multi-drug resistant viruses. A Phase 1 clinical study has been completed demonstrating that the compound is well tolerated and that the active antiviral, TFV-PP, was measurable in peripheral blood mononuclear cells (PBMCs) after a single dose and remained detectable for six days, indicating that it may be suitable for once-weekly dosing. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, flu, malaria and other global public health needs.
show less
Website | chimerix.com | |
Industry | Pharmaceuticals | |
Location | Durham, North Carolina, United States | |
Employees | 68 |
HQ | 2505 Meridian Parkway Suite 340 | |
Phone | 919-313-6782 | |
info@chimerix-inc.com | ||
Funding | 441,249,178 USD | |
Competitors | Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer, |
Website | chimerix.com | |
Industry | Pharmaceuticals | |
Location | Durham, North Carolina, United States | |
Employees | 68 | |
linkedin.com/company/chimerix-inc- | ||
HQ | 2505 Meridian Parkway Suite 340 | |
Phone | 919-313-6782 | |
info@chimerix-inc.com | ||
Funding | 441,249,178 USD |
Email Patterns for Chimerix, Inc.
Top Competitors for Chimerix, Inc.
Chimerix, Inc. Questions
Where are Chimerix, Inc.'s headquarters?
Chimerix, Inc.'s headquarters are in 2505 Meridian Parkway Suite 340
What is Chimerix, Inc.'s phone number?
Chimerix, Inc.'s phone number is 9193136782
What is Chimerix, Inc.'s official website?
Chimerix, Inc.'s website is chimerix.com
How many employees are working in Chimerix, Inc. right now?
Chimerix, Inc. has
68 employees.
View the Email and Phone Numbers for all 68 working at Chimerix, Inc..
What is Chimerix, Inc.'s industry?
Chimerix, Inc.'s industry is
Pharmaceuticals
Who are Chimerix, Inc.'s top competitors?
Chimerix, Inc.'s top competitors are
Walgreens Boots Alliance
,
Pfizer
,
Cvs Health
,
Novartis
,
Gsk
,
Bayer
What is Chimerix, Inc.'s email address?
Chimerix, Inc.'s email address is info@chimerix-inc.com
What are Chimerix, Inc.'s categories?
Chimerix, Inc.'s categories are Biotechnology, Health Care, Pharmaceutical
What is Chimerix, Inc.'s location?
Chimerix, Inc.'s location is
Durham, North Carolina, United States
What is Chimerix, Inc.'s funding?
Chimerix, Inc.'s funding is 441,249,178 USD
What is Chimerix, Inc.'s current status?
Chimerix, Inc.'s current status is ipo
Top Chimerix, Inc. Employees
Senior Director, Human Resources
blberg41@hotmail.com
+1919-806-1074
Clinical Development Manager, Associate Director Clinical Pharmacology
maggie.t.anderson@gmail.com
+1919-806-1074
Senior Vice President And General Counsel At Chimerix, Inc
malrutz@trimeris.com
+1919-806-1074
Senior Scientist
yanwu76@yahoo.com
+1919-806-1074
Ap Manager
sbaranchak@rti.org
+1919-806-1074
Vice President Of Strategic Planning And Investor Relations
michelle@alphavax.com
+1919-303-6845
Director, Global Supply Chain
jbutler@chimerix.com
+1919-806-1074